Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Daryoush Samim

Dr Daryoush Samim

Daryoush Samim

MD


Research Facilitator and Clinical Research Fellow

After earning his medical degree from the University of Lausanne, Switzerland, in 2015, Dr Samim completed his internal medicine training at the University Hospital of Lausanne, obtaining board certification in 2020. He then pursued cardiology training at the University Hospital of Bern, Switzerland, achieving board certification in 2024, followed by a fellowship in valvular heart disease. 

In January 2025, he joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) as a research facilitator and clinical research fellow in the Trial Methods Group. His primary focus is on implementing the NAVIGATE Bicuspid trial, an investigator-initiated, multicenter, international, randomised controlled non-inferiority trial.

The study aims to compare transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) in 1,500 patients with severe bicuspid aortic valve stenosis across 150 sites in the USA, Canada, and Europe. The NAVIGATE Bicuspid trial is an internationally endorsed initiative supported by the Global Cardiovascular Research Funders' Forum (GCRFF) Multinational Clinical Trials Initiative. Professor Peter Jüni (CTSU) is the trial methodologist and one of the principal global investigators.